Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I was simply pointing out that it’s a known fact he’s read this board at times bc of specifically naming it in a tweet. I’ve made my feelings known on the rest many times before here.
Chandra has specifically mentioned ihub by name in tweets. It’s obvious that at least he reads what is on this board.
Just because someone isn't CEO anymore doesn't mean they left anyway. The guys nearly 80, maybe he just decided he didn't want the daily ceo responsibilities and wanted to take a back seat role while still seeing the pipeline forward. Really doesn't matter who's CEO if things move forward.
One thing is for sure, regardless of any speculation going on.
The Cotropia's are NOT just going to abandon or hand over Clone 3 after all the years of work. And their name is still on all the filed patents, so their not about to hand over or abandon those either.
Charles doesn't need to be ceo for the entire pipeline to still advance forward. Doesn't matter if he's just a board member, what matters is if the assets under BGEN and VIRO that were in the SAGA deal are back under ENZC or not. That's what we are waiting for clarification on.
And if Chandra cared at all about shareholders, he would have taken over the CEO position offered and made things right. They said he declined. None of this makes any sense.
Hey “we won” remember? Smfh…
“Leave me alone” lol. That’s be rich, coming from Chandra. He’s the one that put himself out there bc he thought he was some social media celebrity with all the shareholder attention he got for three years. And like I said, just weeks ago he made another empty promise to communicate better with shareholders. There isn’t a single thing this guys promised that’s panned out. The guy is completely full of shit.
He’s likely talking about projects involving things outside the specific realm of what ENZC and sub are working on, such as the recent work with IBM. The AI program here is clearly too small and with too few people involved to handle a broader scope of all the world’s medical issues and diseases. That’s what I took from it.
As usual though the guy has a big fucking blabber mouth and just causes more confusion on this side with shareholders. Especially when he leads shareholders on dangling carrots then not following up. The biggest problem here for over three years is Chandra and his loose lips on social media.
Lmao. He literally just stated a few weeks ago that they needed to do better with shareholder communication and would do so. Makes no sense he’d just be leaving at this point. The speculation here is ridiculous as always.
Looks like a entry in Canada was also posted.
At least it's good to see some progress is indeed going on behind the scenes, despite the lack of shareholders updates or communication.
Why would they not come out and clarify things then?
That’s assuming that the patent applications and the assets are back under ENZC. Since they can’t be bothered to update shareholders on anything, we don’t have a clue where the value lies at this point.
Like I said many times, I was in back in 2020 under half a penny and I’m only now holding free shares, so I’m not concerned. I’ll decide on the rest of these once we find out where the main assets went / are / or are going.
What do you feel is a realistic market cap upon approval?
Give him credit. He’s trying hard. But the desperation is showing.
Maybe he can fill us in on what assets are still here that he’s after.
I think we can narrow it down to a handful.
More importantly, it goes to show there's people trying to fight over whatever assets currently remain here. People don't waste this much time and effort unless they believe there's a big payday in it for them.
Well one thing is certain. New bashers claiming to represent old insiders don’t just show up at a time like this. Not to flip for 10% or so. And a new lawsuit was recently filed also. Shows there’s still major value or no one would bother. Something is up.
There's a difference between voicing an opinion and telling people what to do over and over and over again.
You truly are an idiot
Read the top stickied post
Now that we know they can't r/s for at least a year, wonder where this goes in the meantime. Might have to consider a larger stake now. Pretty big deal that we're safe from an r/s (even if they plan to go through with one) for at least 12 months.
Huge info. Great post.
Welcome to what is an internet message board. Where people share their thoughts on the topic at hand. We’re free to share whatever opinion we have without being told relentlessly we must forward it via certified mail to the company ceo lmao. Give it a rest already.
It’s definitely needed eventually and a good thing obviously for multiple reasons but it’s not a reason for delays in the trial progress they should already be making here.
Yawn
They don’t need patents granted to go to clinical trials. There’s patent pending protection for a reason.
Not to mention Charles himself laid out a roadmap here in early 2021 and they’ve failed about as bad as imaginably possible on meeting any of those. Remember spring 2021 when he put some of the trials 6 months out lol? Animal testing at UC Davis, the hell ever happened to that or the others? Don’t get me started on Chandras claims. Here we are 3 years later and now apparently the plan is “animal trials soon”.
Give it a rest already with the "mail them a letter" bullshit.
You realize none of those are approved yet and the scope of which he applied for them is likely not going to fully be approved either? Parts of the applications may eventually get approved, but just bc he applied for them in a broad way currently means nothing.
Lmfao...
Appreciate the factual info unlike the other response.
Let's stop calling someone a genius for filing some damn patents. Anyone can do that. A genius also wouldn't have steered this disaster the last 3 years in the direction its gone.
Are there any sort of reciprocal approvals (or maybe shorter required clinical trials) with the EUA or FDA once they get the UK'S MHRA approval?
It was not from August, the article is no longer available and someone pulled it from that site yesterday. You're now looking at what remains, with the one other article dated from August.
The article that was originally there and pulled yesterday talked about information that occurred after the late September ENZC/ SAGA business combination was completed. Yet, it didn't speak of any lawsuit or Nasdaq issues, so it was most likely written in October or November. Regardless, someone on the companies side had that pulled quickly after it was posted here yesterday.
"Something's not right, either they don't have what they claimed to have, or they have something else to hide."
100% agreed
Great post
Appreciate the info!
Been in other bios about that long and can relate. I was only told about NWBO in the last few months and have been on the sidelines watching. I feel like a starter near these prices seems like a good price and time to get in finally. For someone new here I can also say it's very difficult to get accurate info and do proper DD, as this seems to have some of the most relentless bashing I've ever seen on this site or others.
Interesting, someone had that pulled fast. Now I'm 100% convinced they watch this ENZC board here on IHUB.
It would have been perfect to publish this back in November but now it's misinformation and much of it's no longer accurate. What would be nice is if the company actually released thourough and right to the point news like this article is every few months to keep us fully informed where things stand.
May be dated today but it's completed outdated info and you can tell it was written back before the lawsuit and Nasdaq problems if you pay close attention to a few specific statements within it.